A Study to Evaluate the Efficacy of an Acellular Dermal Template for the Treatment of Full Thickness Skin Defects
A Phase 2, Intra-patient Randomised Controlled Multicentre International Study to Evaluate the Efficacy of an Acellular Dermal Template Novomaix for the Treatment of Full Thickness Skin Defects
Sponsor: Association of Dutch Burn Centres
Listed as NCT02373566, this NA trial focuses on Full Thickness Skin Defects and remains completed. Sponsored by Association of Dutch Burn Centres, it has been updated 7 times since 2015, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Mar 2020 — Jan 2021 [monthly]
Completed NA
Status: Unknown Status → Completed · Phase: PHASE2 → NA
-
Jun 2018 — Mar 2020 [monthly]
Unknown Status PHASE2
▶ Show 2 earlier versions
-
Oct 2017 — Jun 2018 [monthly]
Unknown Status PHASE2
Status: Recruiting → Unknown Status
-
Jan 2017 — Oct 2017 [monthly]
Recruiting PHASE2
First recorded
Feb 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Association of Dutch Burn Centres
- Ernst Reichmann Tissue Biology Research Unit, Zürich
- Seventh Framework Programme
For direct contact, visit the study record on ClinicalTrials.gov .